Pages that link to "Q46924646"
Jump to navigation
Jump to search
The following pages link to Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: results of a phase I clinical trial (Q46924646):
Displaying 50 items.
- Exome sequencing identifies truncating mutations in human SERPINF1 in autosomal-recessive osteogenesis imperfecta (Q24594147) (← links)
- Effects of human recombinant PEDF protein and PEDF-derived peptide 34-mer on choroidal neovascularization (Q24630406) (← links)
- Clinical Trials in Retinal Dystrophies (Q26767086) (← links)
- Microvascular complications and diabetic retinopathy: recent advances and future implications (Q26822476) (← links)
- Immunology of AAV-Mediated Gene Transfer in the Eye (Q27023474) (← links)
- Transscleral sustained vasohibin-1 delivery by a novel device suppressed experimentally-induced choroidal neovascularization (Q28487648) (← links)
- Hypoxia-induced upregulation of pigment epithelium-derived factor by retinal glial (Müller) cells (Q28572018) (← links)
- Expression of vascular endothelial growth factor and pigment epithelial-derived factor in a rat model of retinopathy of prematurity (Q28583644) (← links)
- Optimizing atoh1-induced vestibular hair cell regeneration. (Q30364993) (← links)
- A review of gene delivery and stem cell based therapies for regenerating inner ear hair cells (Q30436837) (← links)
- Pigment Epithelium-Derived Factor Gene Polymorphisms in Exudative Age-Related Degeneration in a Chinese Cohort (Q30993369) (← links)
- Macrophages inhibit neovascularization in a murine model of age-related macular degeneration (Q33253660) (← links)
- A review of drug options in age-related macular degeneration therapy and potential new agents (Q33263803) (← links)
- Alternate serotype adenovector provides long-term therapeutic gene expression in the eye. (Q33397385) (← links)
- Prospects for nanomedicine in treating age-related macular degeneration (Q33424022) (← links)
- Current and emerging therapies for the treatment of age-related macular degeneration (Q33492370) (← links)
- An empty E1, E3, E4 adenovirus vector protects photoreceptors from light-induced degeneration (Q33574612) (← links)
- Adenovirus vectors targeting distinct cell types in the retina (Q33845053) (← links)
- A Non Membrane-Targeted Human Soluble CD59 Attenuates Choroidal Neovascularization in a Model of Age Related Macular Degeneration (Q33892696) (← links)
- Leber congenital amaurosis due to RPE65 mutations and its treatment with gene therapy (Q33992484) (← links)
- Evaluation of adenovirus-delivered human CD59 as a potential therapy for AMD in a model of human membrane attack complex formation on murine RPE. (Q34069606) (← links)
- Genetics of age-related macular degeneration: application to drug design (Q34103580) (← links)
- Ocular localization and transduction by adenoviral vectors are serotype-dependent and can be modified by inclusion of RGD fiber modifications (Q34215308) (← links)
- The potential of nanomedicine therapies to treat neovascular disease in the retina. (Q34220590) (← links)
- Ranibizumab: the evidence of its therapeutic value in neovascular age-related macular degeneration. (Q34449898) (← links)
- Vector platforms for gene therapy of inherited retinopathies. (Q34561531) (← links)
- Decay Accelerating Factor (CD55)–Mediated Attenuation of Complement: Therapeutic Implications for Age-Related Macular Degeneration (Q34662323) (← links)
- Gene Transfer for Neovascular Age-Related Macular Degeneration (Q34843778) (← links)
- Adenovector-mediated gene delivery to human umbilical cord mesenchymal stromal cells induces inner ear cell phenotype (Q34983847) (← links)
- Extra cellular matrix derived metabolite regulates angiogenesis by FasL mediated apoptosis (Q35063753) (← links)
- MicroRNA-410 reduces the expression of vascular endothelial growth factor and inhibits oxygen-induced retinal neovascularization (Q35159008) (← links)
- Gene therapy for ocular diseases (Q35160142) (← links)
- Future therapies of wet age-related macular degeneration. (Q35162495) (← links)
- Gene Therapy with Endogenous Inhibitors of Angiogenesis for Neovascular Age-Related Macular Degeneration: Beyond Anti-VEGF Therapy (Q35188790) (← links)
- Development of gene therapy for treatment of age-related macular degeneration (Q35192906) (← links)
- Republished review: Gene therapy for ocular diseases (Q35210756) (← links)
- Association of PEDF polymorphisms with age-related macular degeneration and polypoidal choroidal vasculopathy: a systematic review and meta-analysis (Q35227249) (← links)
- Current status of gene delivery and gene therapy in lacrimal gland using viral vectors. (Q35594134) (← links)
- Opposing effects of pigment epithelium-derived factor on breast cancer cell versus neuronal survival: implication for brain metastasis and metastasis-induced brain damage (Q35662043) (← links)
- Effect of verteporfin photodynamic therapy on endostatin and angiogenesis in human choroidal neovascular membranes (Q35762984) (← links)
- Gene Therapies for Neovascular Age-Related Macular Degeneration (Q35795572) (← links)
- miR-126 Regulation of Angiogenesis in Age-Related Macular Degeneration in CNV Mouse Model (Q36060465) (← links)
- miRNA involvement in angiogenesis in age-related macular degeneration (Q36062736) (← links)
- Prospectives for gene therapy of retinal degenerations (Q36108106) (← links)
- The physiological impact of microRNA gene regulation in the retina (Q36238203) (← links)
- The liberation of CD44 intracellular domain modulates adenoviral vector transgene expression (Q36294870) (← links)
- Molecular pathogenesis of retinal and choroidal vascular diseases (Q36296789) (← links)
- Antiangiogenic and Neurogenic Activities of Sleeping Beauty-Mediated PEDF-Transfected RPE Cells In Vitro and In Vivo (Q36369034) (← links)
- Early responses to adenoviral-mediated transfer of the aquaporin-1 cDNA for radiation-induced salivary hypofunction (Q36436807) (← links)
- AAV-mediated gene transfer for retinal diseases (Q36708300) (← links)